Douglas W. Hoffman

1.3k total citations
37 papers, 975 citations indexed

About

Douglas W. Hoffman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Douglas W. Hoffman has authored 37 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Cellular and Molecular Neuroscience and 7 papers in Sensory Systems. Recurrent topics in Douglas W. Hoffman's work include Neuropeptides and Animal Physiology (16 papers), Receptor Mechanisms and Signaling (12 papers) and Hearing, Cochlea, Tinnitus, Genetics (5 papers). Douglas W. Hoffman is often cited by papers focused on Neuropeptides and Animal Physiology (16 papers), Receptor Mechanisms and Signaling (12 papers) and Hearing, Cochlea, Tinnitus, Genetics (5 papers). Douglas W. Hoffman collaborates with scholars based in United States. Douglas W. Hoffman's co-authors include Richard A. Altschuler, Richard P. Bobbin, Leonard P. Rybak, Stephen W. White, Charles C. Query, Barbara L. Golden, Jack D. Keene, Craig Whitworth, Jörgen Fex and Marianne H. Parakkal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Biochemistry and Brain Research.

In The Last Decade

Douglas W. Hoffman

37 papers receiving 945 citations

Peers

Countries citing papers authored by Douglas W. Hoffman

Since Specialization

Citations

This map shows the geographic impact of Douglas W. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Hoffman more than expected).

Fields of papers citing papers by Douglas W. Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas W. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Hoffman. The network helps show where Douglas W. Hoffman may publish in the future.

Co-authorship network of co-authors of Douglas W. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W. Hoffman. A scholar is included among the top collaborators of Douglas W. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W. Hoffman. Douglas W. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics 2010 ·Bioorganic & Medicinal Chemistry Letters ·Qingping Zeng, Matthew P. Bourbeau, (unknown), (unknown), Holger Monenschein, (unknown), Matthew R. Lee, Shiwen Zhang, Julie A. Lofgren, Daniel J. Freeman, Chun Li, (unknown), Xin Huang, Douglas W. Hoffman, Harvey Yamane, Andrew S. Tasker, Celia Dominguez, Vellarkad N. Viswanadhan, Randall W. Hungate, Xiaoling Zhang	15
2	Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Serum With Solid-Phase Extraction and High-Performance Liquid Chromatography 1997 ·Therapeutic Drug Monitoring ·(unknown), Douglas W. Hoffman	26
3	Inhibition of glutathione-related enzymes and cytotoxicity of ethacrynic acid and cyclosporine 1995 ·Biochemical Pharmacology ·Douglas W. Hoffman, Philip Wiebkin, Leonard P. Rybak	17
4	Solid-Phase Extraction and High-Performance Liquid Chromatography for Therapeutic Monitoring of Haloperidol Levels 1994 ·Therapeutic Drug Monitoring ·Douglas W. Hoffman, (unknown)	8
5	Localization of preproenkephalin mRNA-expressing cells in rat auditory brainstem with in situ hybridization 1993 ·Hearing Research ·Douglas W. Hoffman, (unknown), (unknown), (unknown), Melinda D. Treadwell, Paul Gardner, Richard A. Altschuler	10
6	Comparison of cyclosporine and FK506 effects on glutathione levels in rat cochlea, brain, liver and kidney 1992 ·Biochemical Pharmacology ·(unknown), Leonard P. Rybak, Douglas W. Hoffman	13
7	Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function 1991 ·Hearing Research ·Tony L. Sahley, (unknown), Frank E. Musiek, Douglas W. Hoffman	30
8	An Introduction to the Functional Neurochemistry of the Auditory System 1990 ·Ear and Hearing ·Frank E. Musiek, Douglas W. Hoffman	5
9	Lateral olivocochlear neurons contain both enkephalin and dynorphin immunoreactivities: immunocytochemical co-localization studies. 1988 ·Journal of Histochemistry & Cytochemistry ·Richard A. Altschuler, (unknown), J. Fex, Douglas W. Hoffman	29
10	Putative neurotransmitters in the rat cochlea at several ages 1988 ·Brain Research ·Douglas W. Hoffman, (unknown), Richard A. Altschuler	6
11	Electrochemical detection for high-performance liquid chromatography of ketoconazole in plasma and saliva 1988 ·Analytical Biochemistry ·Douglas W. Hoffman, (unknown), C. Lewis Ravaris, (unknown)	15
12	Nutritional status, glutathione levels, and ototoxicity of loop diuretics and aminoglycoside antibiotics 1987 ·Hearing Research ·Douglas W. Hoffman, Craig Whitworth, (unknown), Leonard P. Rybak	41
13	New high-performance liquid chromatographic method for fluphenazine and metabolites in human plasma 1987 ·Journal of Chromatography B Biomedical Sciences and Applications ·Douglas W. Hoffman, (unknown), Samuel D. Shillcutt, (unknown)	7
14	Glutathione depletion markedly enhances drug induced hearing loss possible mechanism of ototoxicity 1986 ·The Society for Neuroscience Abstracts ·Douglas W. Hoffman, Craig Whitworth, (unknown), Leonard P. Rybak	3
15	Localization and quantitation of dynorphin B in the rat hippocampus 1984 ·Brain Research ·Douglas W. Hoffman, Nadav Zamir	18
16	Chromatographic identification of enkephalins in the guinea pig retina 1983 ·Neuroscience Letters ·Douglas W. Hoffman	9
17	High-performance liquid chromatographie identification of enkephalin-like peptides in the cochlea 1983 ·Hearing Research ·Douglas W. Hoffman, Richard A. Altschuler, Jörgen Fex	36
18	Development and Aging of Cholinergic Synapses 1980 ·Developmental Neuroscience ·(unknown), Douglas W. Hoffman, Ezio Giacobini, (unknown)	12
19	Development and Aging of Cholinergic Synapses 1980 ·Developmental Neuroscience ·Mario Marchi, Douglas W. Hoffman, (unknown), Mario Giacobini	14
20	Canada's natural environment : essays in applied geography 1976 ·Methuen eBooks ·Geoff McBoyle, (unknown), (unknown), James S. Gardner, (unknown), (unknown), (unknown), Douglas W. Hoffman, (unknown), John B. Theberge, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact